Differential activation of nuclear factor-kappa B by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly

Shona M. McFarlane, Ghazaleh Pashmi, Michelle C. Connell, Alison F. Littlejohn, Steven J. Tucker, Peter Vandenabeele, David J. MacEwan

    Research output: Contribution to journalArticlepeer-review

    79 Citations (Scopus)

    Abstract

    Tumour necrosis factor-alpha (TNF-alpha) signals though two receptors, TNFR1 and TNFR2. TNFR1 has a role in cytotoxicity, whereas TNFR2 regulates death responses or proliferation. TNF activates pro-inflammatory transcription factor nuclear factor-kappaB (NF-kappaB) by uncertain signalling mechanisms. Here we report the contribution of each TNFR towards the NF-kappaB activation processes. In human cells expressing endogenous or exogenous TNFR2, in addition to TNFR1, we found both TNFRs capable of activating NF-kappaB as measured by IkappaBalpha (inhibitor of NF-kappaB) degradation, electrophorefic mobility shift assay and NF-kappaB gene reporter assays. TNFR2 activation did not degrade IkappaBbeta. However, TNF-effects on NF-kappaB activation occurred predominantly through TNFR1, with TNFR2 activating the transcription factor poorly. (C) 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
    Original languageEnglish
    Pages (from-to)119-126
    Number of pages8
    JournalFEBS Letters
    Volume515
    Issue number1-3
    DOIs
    Publication statusPublished - 2002

    Keywords

    • CELL-DEATH
    • CYTOTOXICITY
    • INDUCTION
    • tumour
    • PROLIFERATION
    • signal transduction
    • SIGNALING PATHWAY
    • kinase
    • APOPTOSIS
    • cytokine
    • receptor
    • subtype
    • IDENTIFICATION
    • DOMAIN
    • KINASE
    • ALPHA

    Cite this